Stroke, Vol 25, 2235-2240, Copyright © 1994 by American Heart Association
J Aronowski, P Ostrow, E Samways, R Strong, JA Zivin and JC Grotta
BACKGROUND AND PURPOSE: This study explored the correlation between
duration of focal ischemia and infarct volume in spontaneously hypertensive
rats as a measure of outcome after neuroprotective intervention. METHODS:
We used 2,3,5-triphenyltetrazolium chloride staining to discriminate
infarcted tissue and calculate infarct volume 24 hours after temporary
tandem common carotid/middle cerebral artery occlusion lasting 5 to 150
minutes. We used a graded bioassay described by logistic function and
executed by computer program (ALLFIT) to evaluate changes in infarct volume
after increasing durations of ischemia. The method allowed us to calculate
the maximal infarct volume (Volmax) and the duration of ischemia before
reperfusion producing half- maximal infarct size (T50). Hypothermia and the
N-methyl-D-aspartate antagonist CNS-1102 begun after the onset of ischemia
were tested for their ability to reduce Volmax and prolong T50 as analyzed
by ALLFIT. RESULTS: Volmax was 180.6 +/- 22.4 mm3 and T50 was 45.9 +/- 5.8
minutes in control rats. Hypothermia (30 degrees C) applied during ischemia
reduced Volmax by 66 mm3 and extended T50 by 50% (P < .05 for each
comparison). CNS-1102, like hypothermia, extended T50 by 44% but did not
have an effect on Volmax. CONCLUSIONS: Analysis of the changes of infarct
size after increasing durations of ischemia indicates that although both
were protective, the two treatments tested may exhibit different profiles
of efficacy. This method of analyzing ischemia- induced damage may be very
sensitive for studying the efficacy and possible clinical use of neuronal
protective therapies for hyperacute stroke.
ARTICLES
Graded bioassay for demonstration of brain rescue from experimental acute ischemia in rats
Department of Neurology, University of Texas Medical School, Houston 77030.
This article has been cited by other articles:
![]() |
J. Aronowski, R. Strong, A. Shirzadi, and J. C. Grotta Ethanol Plus Caffeine (Caffeinol) for Treatment of Ischemic Stroke: Preclinical Experience Stroke, May 1, 2003; 34(5): 1246 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Christou, A. V. Alexandrov, W. S. Burgin, A. W. Wojner, R. A. Felberg, M. Malkoff, and J. C. Grotta Timing of Recanalization After Tissue Plasminogen Activator Therapy Determined by Transcranial Doppler Correlates With Clinical Recovery From Ischemic Stroke Stroke, August 1, 2000; 31(8): 1812 - 1816. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Dyker, K. R. Edwards, P. B. Fayad, J. T. Hormes, and K. R. Lees Safety and Tolerability Study of Aptiganel Hydrochloride in Patients With an Acute Ischemic Stroke Stroke, October 1, 1999; 30(10): 2038 - 2042. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Grotta Acute Stroke Therapy at the Millennium: Consummating the Marriage Between the Laboratory and Bedside : The Feinberg Lecture Stroke, August 1, 1999; 30(8): 1722 - 1728. [Full Text] [PDF] |
||||
![]() |
J. Vogel, C. Mobius, W. Kuschinsky, and W. I. Rosenblum Early Delineation of Ischemic Tissue in Rat Brain Cryosections by High-Contrast Staining • Editorial Comment Stroke, May 1, 1999; 30(5): 1134 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bochelen, M. Rudin, and A. Sauter Calcineurin Inhibitors FK506 and SDZ ASM 981 Alleviate the Outcome of Focal Cerebral Ischemic/Reperfusion Injury J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 653 - 659. [Abstract] [Full Text] |
||||
![]() |
J. Aronowski, R. Strong, J.C. Grotta, and H. A. Kontos Combined Neuroprotection and Reperfusion Therapy for Stroke: Effect of Lubeluzole and Diaspirin Cross-Linked Hemoglobin in Experimental Focal Ischemia Stroke, September 1, 1996; 27(9): 1571 - 1577. [Abstract] [Full Text] |
||||
![]() |
E. J. Goldlust, R. P. Paczynski, Y. Y. He, C. Y. Hsu, M. P. Goldberg, and M. Fisher Automated Measurement of Infarct Size With Scanned Images of Triphenyltetrazolium Chloride–Stained Rat Brains Stroke, September 1, 1996; 27(9): 1657 - 1662. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |